Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.

Jacobson, J M

Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers. [electronic resource] - The Journal of infectious diseases Jan 2001 - 343-346 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0022-1899

10.1086/317928 doi


Anti-HIV Agents--administration & dosage
Double-Blind Method
HIV Infections--complications
Humans
Immunosuppressive Agents--administration & dosage
Recurrence
Stomatitis, Aphthous--complications
Thalidomide--administration & dosage
Treatment Failure